Almost to the level of saturation, there have been a remarkably high number of articles and publications examining the impact of COVID-19 on the US healthcare system. Precision’s Ryan Cox takes a look at some of the less-mentioned trends hinting at changes coming to health systems in the near future.
Team members Ryan Cox and Erin Lopata examine consolidation among health systems. Will this trend lead to lower costs and better care or should stakeholders be more concerned with the growing power of the industry heavyweights?
Ryan Cox outlines the recent efforts of his previous employer, Highmark BCBS, and their creation of the Highmark Cancer Collective to promote evidence-based treatment pathways.